Therapeutic Duel of Rifaximin Versus Lactulose in Hepatic Encephalopathy: A Systematic Review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Therapeutic Duel of Rifaximin Versus Lactulose in Hepatic Encephalopathy: A Systematic Review

Published:2025-06-17 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Oriko David O,Khawaj Zainab,Cheema Muhammad Usairam,Talreja Anjali,Tayyab Muhammad Abbas,Zamir Muhammad Hamza,Iqbal Maheen,Farooq Umer,Ekomwereren Osatohanmwen,Tariq Muhammad M,Hasan Abdul Haseeb

Publisher

Springer Science and Business Media LLC

Reference25 articles.

1. Pathogenesis of hepatic encephalopathy in chronic liver disease;Ochoa-Sanchez R;J Clin Exp Hepatol,2018

2. Hepatic encephalopathy: an update on the pathophysiology and therapeutic options;Elwir S;J Clin Transl Hepatol,2017

3. Poor disease knowledge is associated with higher healthcare service use and costs among patients with cirrhosis: an exploratory study;Valery PC;BMC Gastroenterol,2022

4. Lactulose in cirrhosis: current understanding of efficacy, mechanism, and practical considerations;Bloom PP;Hepatol Commun,2023

5. Rifaximin treatment for reduction of risk of overt hepatic encephalopathy recurrence;Flamm SL;Therap Adv Gastroenterol,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.7亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP